Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynette Keyes-Elstein

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Southern Medical Journal|January 31, 2006
Factors that affect parental disciplinary practices of children aged 12 to 19 monthsRebecca R S Socolar, Eric Savage, Lynette Keyes-Elstein, et al.
Clinical Therapeutics|May 23, 2016
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL TrialAshley Pinckney, Mark R Rigby, Lynette Keyes-Elstein, et al.
BMJ (Clinical Research Ed.)|February 10, 2004
Practice based education to improve delivery systems for prevention in primary care: randomised trialPeter A Margolis, Carole M Lannon, Jayne M Stuart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United StatesChitra Hosing, Richard Nash, Peter McSweeney, et al.
Diabetes|July 10, 2013
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of respondersKevan C Herold, Stephen E Gitelman, Mario R Ehlers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B CellsNida Meednu, Jennifer Barnard, Kelly Callahan, et al.
Annals of the Rheumatic Diseases|October 14, 2022
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosisJulia Z Adamska, Amin Zia, Michelle S Bloom, et al.
Annals of the Rheumatic Diseases|January 18, 2023
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantationBurcu Ayoglu, Michele Donato, Daniel E Furst, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Southern Medical Journal|January 31, 2006
Factors that affect parental disciplinary practices of children aged 12 to 19 monthsRebecca R S Socolar, Eric Savage, Lynette Keyes-Elstein, et al.
Clinical Therapeutics|May 23, 2016
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL TrialAshley Pinckney, Mark R Rigby, Lynette Keyes-Elstein, et al.
BMJ (Clinical Research Ed.)|February 10, 2004
Practice based education to improve delivery systems for prevention in primary care: randomised trialPeter A Margolis, Carole M Lannon, Jayne M Stuart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United StatesChitra Hosing, Richard Nash, Peter McSweeney, et al.
Diabetes|July 10, 2013
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of respondersKevan C Herold, Stephen E Gitelman, Mario R Ehlers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B CellsNida Meednu, Jennifer Barnard, Kelly Callahan, et al.
Annals of the Rheumatic Diseases|October 14, 2022
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosisJulia Z Adamska, Amin Zia, Michelle S Bloom, et al.
Annals of the Rheumatic Diseases|January 18, 2023
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantationBurcu Ayoglu, Michele Donato, Daniel E Furst, et al.
Pageof 3